1410. Isoniazid Therapy for Latent Tuberculosis Infection in Patients with Cancer Treated with Checkpoint Inhibitors Immunotherapy

BACKGROUND: Data on the efficacy and tolerability of latent tuberculosis infection (LTBI) treatment in cancer patients receiving checkpoint inhibitor immunotherapy (CPI) is limited. We sought to assess LTBI therapy and its adverse events and outcomes in patients treated with CPI. METHODS: We perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Malek, Alexandre, Chaftari, Patrick, Okhuysen, Pablo C, Dagher, Hiba, Torres, Harrys A, Hachem, Ray Y, Chaftari, Anne-Marie, Viola, George, Kontoyiannis, Dimitrios P, Mulanovich, Victor E, Raad, Issam I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644907/
http://dx.doi.org/10.1093/ofid/ofab466.1602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644907/
http://dx.doi.org/10.1093/ofid/ofab466.1602

Ejemplares similares